Milestone achieved: FDA approves nivolumab in combination with cisplatin and gemcitabine for metastatic urothelial carcinoma.

Ann Med Surg (Lond)

Department of Research, Medical Research Circle (MedReC), Goma, Democratic Republic of Congo.

Published: November 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543197PMC
http://dx.doi.org/10.1097/MS9.0000000000002601DOI Listing

Publication Analysis

Top Keywords

milestone achieved
4
achieved fda
4
fda approves
4
approves nivolumab
4
nivolumab combination
4
combination cisplatin
4
cisplatin gemcitabine
4
gemcitabine metastatic
4
metastatic urothelial
4
urothelial carcinoma
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!